NEW YORK, April 7 - Applied Biosystems, HTS Biosystems, and Mitsubishi Chemical today announced a distribution agreement for a next-generation surface-plasmon resonance (SPR) system currently under development at HTS.
Under the agreement, Applied Biosystems Japan, a division of ABI, will be the exclusive distributor of the SPR system, which is designed to profile and characterize biomolecular interactions. The three companies also plan to co-develop new applications for the system, which ABI is targeting for worldwide commercial release by the mid-2003.
In 2000, HTS Biosystems granted Mitsubishi Chemical rights to distribute the SPR system once commercialized in Japan; and in April 2002, HTS and ABI entered a licensing and supply agreement to develop and commercialize the technology. Under the new agreement, HTS and Mitsubishi Chemical have granted ABI Japan exclusive distribution rights.